Prosecution History Disclaimer and Estoppel Lead To Noninfringement
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
TRAXCELL TECHNOLOGIES, LLC V. NOKIA SOLUTIONS AND NETWORKS
Before Prost, O’Malley, and Stoll. Appeal from the Eastern District of Texas.
Summary: An applicant’s arguments distinguishing prior art during patent prosecution constituted a disclaimer of claim scope and estopped the patentee from relying on the doctrine of equivalents to show infringement.
Traxcell sued Nokia for infringing three patents related to self-optimizing wireless networks. The district court construed the claim term “location” to mean “location that is not merely a position in a grid pattern,” and “first computer” or “computer” to mean a single computer that can perform each function the claims required. Based on these constructions, the district court granted summary judgment of noninfringement. Traxcell appealed.
The Federal Circuit affirmed the construction of “location” because during prosecution the patent applicant had disclaimed “locations in a grid pattern” by distinguishing prior art. The court also affirmed the judgment of noninfringement based on this limitation because Nokia’s unrebutted expert testimony showed that the accused product used only a grid-pattern location.
As to “first computer” and “computer,” the Federal Circuit again found disclaimer based on the applicant’s arguments during prosecution. Further, the court determined that Traxcell had surrendered multiple-computer equivalents during prosecution. And because Traxcell failed to provide evidence of literal infringement under the Federal Circuit’s construction of “computer” and “first computer,” the court affirmed the judgment of noninfringement based on these limitations.
Editor: Paul Stewart
Written by: Ashley C. Morales & Jeremy Anapol
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…